Clinical Trial Update: Tisseel® as a Reinforcement of Esophagojejunal Anastomoses [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Tisseel as reinforcement of esophagojejunal anastomoses in gastric cancer patients to reduce anastomotic leaks.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anastomotic Leak
• Gastric Cancer

Drugs mentioned

• Tisseel (fibrin sealant)

Snippet

Sponsor: Germans Trias i Pujol Hospital | Conditions: Gastric Cancer, Anastomotic Leak | Phase 4 | Status: UNKNOWN